USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
01 Mar 2023 | 03:45 PM GMT

Beyond Pharma: Finding the Best Commercial Partner for Digital Health in Oncology

Anchored by:

Lavi Kwiatkowsky
Founder & CEO
CANOPY

Participants:

Lavi Kwiatkowsky Founder & CEOCanopy
Lavi Kwiatkowsky
Founder & CEOCanopy
Francesca Wuttke Founder & CEOnen Health
Francesca Wuttke
Founder & CEOnen Health
Alex Holroyd-Smith Head of Business DevelopmentAlvie Health
Alex Holroyd-Smith
Head of Business DevelopmentAlvie Health
Cathy Zaremba Director, Product MarketingBrightInsight
Cathy Zaremba
Director, Product MarketingBrightInsight
Cici Ceralde Director of Venture InsightsMcKesson
Cici Ceralde
Director of Venture InsightsMcKesson
Ivan Jurisic Head of ProductPatients Influence
Ivan Jurisic
Head of ProductPatients Influence
KH
Kaitlin Hemric MarketingCanopy
KH
Kaitlin Hemric
MarketingCanopy
Leo Bekerman ManagerZS Associates
Leo Bekerman
ManagerZS Associates
Marenne Hoogenboom Market Access ManagerOmnigen BV
Marenne Hoogenboom
Market Access ManagerOmnigen BV
Mithun Ratnakumar Director Technology Strategy & GovernanceGerresheimer
Mithun Ratnakumar
Director Technology Strategy & GovernanceGerresheimer
Sarah el Idrissi Digital Health Product ManagerAccord Healthcare
Sarah el Idrissi
Digital Health Product ManagerAccord Healthcare

About this Meeting

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Whilst digital health startups in oncology have tried to build prosperous partnerships with pharma, there are no outstanding results yet, and it has proven hard to make it work. Oncology is a particularly complex area compared to other therapeutic areas, and incorporating digital solutions adds even more complexity for pharma. On top of that, there is the bureaucracy barrier and procurement issues that delay pharma-digital health partnerships. This makes digital health manufacturers in oncology consider other possible commercial partners beyond pharma.

There are several factors for digital health companies to consider when evaluating potential commercial partners in oncology. What other partners can align with their objectives and lead to successful collaborations? Join this session to discuss: 

  • Why may pharma not be the answer? What can we learn? What hasn’t worked when partnering with pharma? What do startups need and where can they find a partner that covers their needs?
  • Possible commercial partners beyond pharma: Pros & Cons. If it is not pharma, what other potential commercial partners should digital health companies consider (e.g. employers, healthcare providers, payers, hospitals, etc.)? 
  • Finding the best commercial partner for your company. What are the factors that digital health companies need to evaluate when searching for commercial partners in oncology? From all the possible partners, who to pick for your particular company?
  • Requirements from the different possible partners. What are the evidence requirements? What is the ask in terms of security, clinical evidence, health economics, interoperability, usability, accessibility, etc.? 
  • Ensuring both short and long-term success in the partnership. What are the short and long-term bets? How to show short-term success/milestones to convince of the long-term value of the partnership? How to build partnerships based on open communication and transparency? 
  • Partners’ expectation on ROI. What does success look like both for the partner and the digital health company? What are the key KPIs to measure success?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.